207
Views
11
CrossRef citations to date
0
Altmetric
Letter to the Editor

Bilateral Posterior Scleritis Associated with Giant Cell Arteritis: A Case Report

, MD, , MD, , MD & , MD
Pages 1244-1247 | Received 12 Feb 2017, Accepted 14 Jun 2017, Published online: 15 Sep 2017

REFERENCES

  • Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, et al. Clinical features and presentation of posterior scleritis: A report of 31 cases. Ocul Immunol Inflamm. 2014 Jun;22(3):203–207.
  • McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: Clinical features, systemic associations, and outcome in a large series of patients. Ophthalmol. 1999 Dec;106(12):2380–6.
  • Cavallini GM, Volante V, Bigliardi MC, et al. Bilateral posterior scleritis as a presenting manifestation of giant cell arteritis: A case report. Can J Ophthalmol. 2014 Dec;49(6):e141–3.
  • Ness T, Auw-Hädrich C, Schmidt D. Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment. Ophthalmol. 2006 Apr;103(4):296–301.
  • Ness T, Bley TA, Schmidt WA, et al. The diagnosis and treatment of giant cell arteritis. Dtsch Arztebl Int. 2013 May;110(21):376–385.
  • Kellar JZ, Taylor BT. Posterior scleritis with inflammatory retinal detachment. West J Emerg Med. 2015 Dec;16(7):1175–1176.
  • Uchihori H, Nakai K, Ikuno Y, et al. Choroidal observations in posterior scleritis using high-penetration optical coherence tomography. Int Ophthalmol. 2014 Aug;34(4):937–943.
  • Stanca HT, Suvac E, Munteanu M, et al. Giant cell arteritis with arteritic anterior ischemic optic neuropathy. Rom J Morphol Embryol. 2017;58(1):281–285.
  • Wang AL, Raven ML, Surapaneni K, Albert DM. Studies on the histopathology of temporal arteritis. Ocul Oncol Pathol. 2017 Jan;3(1):60–65.
  • Kale N, Eggenberger E. Diagnosis and management of giant cell arteritis: A review. Curr Opin Ophthalmol. 2010 Nov;21(6):417–422.
  • Mazlumzadeh M, Hunder GG, Easley KA, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: A double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum. 2006;54: 3310–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.